Praful Bohra of Nirmal Bang Institutional Equities feels Lupin‘s deal with Merck Serano will help the former to make way into incremental markets. Further, he has a positive call on the stock, as he believes recent initiatives taken by the pharma major will be beneficial for business in medium term.
first published: Sep 17, 2014 01:01 pm
A collection of the most-viewed Moneycontrol videos.
Rupee Slide Weighs Heavy As Nifty Tests 25,900| Midcaps See Sharp Cuts| Closing Bell Live
Meesho's Rs 5,421 Cr IPO Kicks Off| Post-IPO Playbook, Profitability Path & More| IPO Watch Live
Can Nifty Hold Above 26,000 Amid Currency Jitters? Meesho IPO Opens | Opening Bell Live
Nifty Struggles Below 26,100 On Weekly F&O Expiry As Rupee Hits New Low| Closing Bell Live
